Lotus Eye Hospital and Institute Ltd (LOTS)

NSE
Currency in INR
74.17
+5.89(+8.63%)
Closed·
LOTS Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
Fair Value
Day's Range
68.1878.49
52 wk Range
52.3590.98
Key Statistics
Edit
Bid/Ask
73.16 / 73.31
Prev. Close
68.28
Open
68.28
Day's Range
68.18-78.49
52 wk Range
52.35-90.98
Volume
1.09M
Average Volume (3m)
58.4K
1-Year Change
21.99%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LOTS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
No news in this category
Looks like there are no results in this news category

Lotus Eye Hospital and Institute Ltd Company Profile

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Employees
336
Market
India

Compare LOTS to Peers and Sector

Metrics to compare
LOTS
Peers
Sector
Relationship
P/E Ratio
301.7x41.2x−0.5x
PEG Ratio
−3.520.810.00
Price/Book
2.6x4.6x2.6x
Price / LTM Sales
3.2x3.6x2.9x
Upside (Analyst Target)
-13.2%60.5%
Fair Value Upside
Unlock−14.6%8.5%Unlock

Earnings

Latest Release
Feb 12, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
122.47M / --
EPS Revisions
Last 90 days

People Also Watch

559.40
JIST
-2.19%
283.70
GTHM
-4.25%
77.05
BLTE
-6.58%
676.85
CHMB
-1.66%

FAQ

What Is the Lotus Eye Hospital Institute (LOTS) Stock Price Today?

The Lotus Eye Hospital Institute stock price today is 74.17

What Stock Exchange Does Lotus Eye Hospital Institute Trade On?

Lotus Eye Hospital Institute is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Lotus Eye Hospital Institute?

The stock symbol for Lotus Eye Hospital Institute is "LOTS."

What Is the Lotus Eye Hospital Institute Market Cap?

As of today, Lotus Eye Hospital Institute market cap is 1.54B.

What is Lotus Eye Hospital Institute Earnings Per Share?

The Lotus Eye Hospital Institute EPS is 0.24.

From a Technical Analysis Perspective, Is LOTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.